Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 35

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 35
---
 reviewed
BioVie’s audited financial statements for the year ended June 30, 2025 and has met with both management and BioVie’s independent
registered public accounting firm, EisnerAmper LLP (“EisnerAmper”), to discuss those financial statements. The Audit Committee
has discussed with EisnerAmper those matters related to the conduct of the audit that are required to be communicated by the independent
registered public accounting firm to the Audit Committee under Auditing Standard 1301, Communications with Audit Committees, issued by
the Public Company Accounting Oversight Board (“PCAOB”), including EisnerAmper’s judgments as to the quality, not just
the acceptability, of BioVie’s accounting principles. In addition, the Audit Committee has reviewed and discussed with management
the assessment of the effectiveness of BioVie’s internal control over financial reporting.

The Audit Committee discussed with BioVie’s independent registered
public accounting firm the overall scope and plans for its audit. The Audit Committee met separately with the independent registered public
accounting firm, without management present, to discuss the results of its audit, BioVie’s internal controls and the overall quality
of BioVie’s financial reporting.

The Audit Committee has received from EisnerAmper the required written
disclosures and letter regarding its independence from BioVie as required by the PCAOB Rule 3526, and has discussed with EisnerAmper its
independence.

Based on these reviews and discussions, the Audit Committee recommended
to the Board of Directors, and the Board of Directors approved, that the audited financial statements of BioVie for the year ended June
30, 2025 be included in BioVie’s Annual Report on Form 10-K for the year ended June 30, 2025, which was filed with the Securities
and Exchange Commission on August 15, 2025.

It is not the duty of the Audit Committee to conduct audits, to independently
verify management’s representations or to determine that BioVie’s financial statements are complete and accurate, prepared
in accordance with United States generally accepted accounting principles or fairly present the financial condition, results of operations
and cash flows of BioVie. Management has the primary responsibility for the financial statements and the reporting process, including
the system of internal control over financial reporting. The independent registered public accounting firm retained by the Audit Committee
is responsible for performing an independent audit of the financial statements, and for reporting the results of their audit to the